Solitary pancreas transplantation for life-threatening allergy to human insulin

Transpl Int. 2006 Jun;19(6):474-7. doi: 10.1111/j.1432-2277.2006.00282.x.

Abstract

We report on a 30-year-old man, with type 1 diabetes mellitus, who developed generalized allergy to insulin consisting of several bouts of tremor, tachycardia, breathlessness and syncope. Strong positive reactions to protamine and metacresol were demonstrated by skin-prick testing. Symptoms persisted despite the use of antihistamine therapy, Actrapid HM Paraben and Monotard (insulin without protamine and metacresol) and immunosuppression (tacrolimus). He underwent a cadaver pancreas transplantation with portal-enteric drainage in June 2003. Following the antithymocyte globulin induction, immunosuppression consisted in tacrolimus and sirolimus without steroids. The patient subsequently reported a complete resolution of his symptoms and excellent glycaemic control. Thirteen months after transplantation, the patient developed oral ulcerations and severe leucopoenia initially attributed to sirolimus, which was subsequently stopped. A hyperglycaemic episode following corticosteroid therapy for acute rejection therapy required the reintroduction of insulin. Allergic manifestations reappeared promptly. Currently, 2 years after transplantation, the patient is euglycaemic without insulin (glycated haemoglobin 5.8%) and he is free of allergic reactions.

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / therapy
  • Homeostasis
  • Humans
  • Hypersensitivity / immunology*
  • Hypersensitivity / therapy*
  • Hypersensitivity, Immediate / therapy*
  • Immunosuppressive Agents / toxicity
  • Insulin / chemistry
  • Insulin / immunology*
  • Insulin Resistance
  • Male
  • Pancreas Transplantation / methods*
  • Protamines / toxicity
  • Sirolimus / toxicity
  • Tacrolimus / toxicity

Substances

  • Immunosuppressive Agents
  • Insulin
  • Protamines
  • Sirolimus
  • Tacrolimus